Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS46001109BKPyvENSG00000169432.19protein_codingSCN9ANoNo6335Q15858
TVIS46001484BKPyvENSG00000169432.19protein_codingSCN9ANoNo6335Q15858
TVIS10044269HBVENSG00000169432.19protein_codingSCN9ANoNo6335Q15858
TVIS30051621HIVENSG00000169432.19protein_codingSCN9ANoNo6335Q15858
TVIS20008037HPVENSG00000169432.19protein_codingSCN9ANoNo6335Q15858
TVIS20055104HPVENSG00000169432.19protein_codingSCN9ANoNo6335Q15858
TVIS44006463HTLV-1ENSG00000169432.19protein_codingSCN9ANoNo6335Q15858
TCGA Plot Options
Drug Information
GeneSCN9A
DrugBank IDDB00281
Drug NameLidocaine
Target IDBE0001143
UniProt IDQ15858
Regulation Typeinhibitor
PubMed IDs17430993; 19088384; 20585544
CitationsSheets PL, Jackson JO 2nd, Waxman SG, Dib-Hajj SD, Cummins TR: A Nav1.7 channel mutation associated with hereditary erythromelalgia contributes to neuronal hyperexcitability and displays reduced lidocaine sensitivity. J Physiol. 2007 Jun 15;581(Pt 3):1019-31. Epub 2007 Apr 12.@@Muroi Y, Chanda B: Local anesthetics disrupt energetic coupling between the voltage-sensing segments of a sodium channel. J Gen Physiol. 2009 Jan;133(1):1-15. doi: 10.1085/jgp.200810103. Epub 2008 Dec 15.@@Karoly R, Lenkey N, Juhasz AO, Vizi ES, Mike A: Fast- or slow-inactivated state preference of Na+ channel inhibitors: a simulation and experimental study. PLoS Comput Biol. 2010 Jun 17;6(6):e1000818. doi: 10.1371/journal.pcbi.1000818.
GroupsApproved; Vet_approved
Direct Classificationm-Xylenes
SMILESCCN(CC)CC(=O)NC1=C(C)C=CC=C1C
PathwaysLidocaine (Antiarrhythmic) Action Pathway; Lidocaine (Local Anaesthetic) Metabolism Pathway; Lidocaine (Local Anaesthetic) Action Pathway
PharmGKBPA450226
ChEMBLCHEMBL79